HIMS – Hims & Hers Health, Inc.

HIMS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

8.79

Margin Of Safety %

Put/Call OI Ratio

0.58

EPS Next Q Diff

-0.09

EPS Last/This Y

-1.34

EPS This/Next Y

0.92

Price

19.64

Target Price

8.15

Analyst Recom

2.4

Performance Q

Upside

N/A

Beta

Ticker: HIMS

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	HIMS	27.75	0.64	0.64	840514
2026-10-15	HIMS	29.4	0.65	0.44	844774
2026-10-16	HIMS	27.96	0.64	0.44	873192
2026-10-19	HIMS	28.24	0.64	0.37	722862
2026-10-20	HIMS	29.23	0.63	0.43	740623
2026-10-21	HIMS	29.19	0.62	0.51	761464
2026-10-22	HIMS	29.09	0.61	0.67	771203
2026-10-23	HIMS	27.7	0.62	0.40	778171
2026-10-26	HIMS	27.55	0.65	0.53	731595
2026-10-27	HIMS	27.9	0.65	0.50	747580
2026-10-28	HIMS	29.4	0.64	0.22	759352
2026-10-29	HIMS	29.67	0.62	0.37	782337
2026-10-30	HIMS	27.68	0.61	0.29	795839
2026-11-02	HIMS	25.23	0.63	0.56	741807
2026-11-03	HIMS	25.73	0.63	0.41	764845
2026-11-04	HIMS	26.66	0.63	0.49	772416
2026-11-05	HIMS	23.85	0.62	0.54	780621
2026-11-06	HIMS	25.95	0.63	0.35	780579
2026-11-09	HIMS	22.9	0.62	0.69	744721
2026-11-10	HIMS	19.04	0.64	0.62	828722
2026-11-11	HIMS	20.77	0.62	0.62	879691
2026-11-12	HIMS	19.75	0.61	0.89	888294
2026-11-13	HIMS	19.74	0.58	0.65	892204
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	HIMS	27.70	-45.4	240.3	-0.56
2026-10-15	HIMS	29.39	-45.4	247.9	-0.56
2026-10-16	HIMS	28.05	-45.4	242.1	-0.56
2026-10-19	HIMS	28.16	-45.4	246.1	-0.56
2026-10-20	HIMS	28.16	-45.4	246.1	-0.56
2026-10-21	HIMS	29.19	-45.4	249.2	-0.56
2026-10-22	HIMS	29.12	-45.4	245.6	-0.56
2026-10-23	HIMS	27.69	-45.4	241.8	-0.56
2026-10-26	HIMS	27.58	-45.4	245.5	-0.56
2026-10-27	HIMS	27.92	-45.4	246.9	-0.56
2026-10-28	HIMS	29.36	-45.4	251.2	-0.56
2026-10-29	HIMS	29.70	-45.4	246.9	-0.56
2026-10-30	HIMS	27.68	-45.4	240.3	-0.56
2026-11-02	HIMS	25.24	-45.4	238.6	-0.56
2026-11-03	HIMS	25.73	-45.4	243.0	-0.56
2026-11-04	HIMS	26.75	-45.4	249.2	-0.56
2026-11-05	HIMS	23.85	-45.4	237.2	-0.56
2026-11-06	HIMS	26.00	-45.4	252.4	-0.56
2026-11-09	HIMS	22.94	-45.4	236.2	-0.56
2026-11-10	HIMS	19.14	-45.4	232.5	-0.56
2026-11-11	HIMS	20.81	-45.4	330.6	-0.56
2026-11-12	HIMS	19.72	-18.0	319.8	-0.77
2026-11-13	HIMS	19.64	-18.0	323.5	-0.77
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

Last Quarter Act. EPS

0.03

Avg. EPS Est. Current Quarter

-0.03

Avg. EPS Est. Next Quarter

-0.06

Insider Transactions

3.89

Institutional Transactions

10.15

Beta

Average Sales Estimate Current Quarter

891

Average Sales Estimate Next Quarter

904

Fair Value

20.65

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

73.1

Max Drawdown 5-Year %

-78.9

Target Price

8.15

P/E

Forward P/E

PEG

P/S

3.05

P/B

3.45

P/Free Cash Flow

EPS

-0.41

Average EPS Est. Cur. Y

-0.77

EPS Next Y. (Est.)

0.15

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-22.2

Relative Volume

0.79

Return on Equity vs Sector %

-80.1

Return on Equity vs Industry %

-60.4

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.21

EBIT Estimation

323.5

No data found for HIMS

HIMS — P/E HistoricalHousehold & Personal Products

Hims & Hers Health, Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 2442

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

HIMS

Latest News

—

Caricamento notizie per HIMS…

stock quote shares HIMS – Hims & Hers Health, Inc. Stock Price stock today

news today HIMS – Hims & Hers Health, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch HIMS – Hims & Hers Health, Inc. yahoo finance google finance

stock history HIMS – Hims & Hers Health, Inc. invest stock market

stock prices HIMS premarket after hours

ticker HIMS fair value insiders trading

PBLS – Parabilis Medicines Inc

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=PBLS#%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

PBLS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

14.26

Margin Of Safety %

Put/Call OI Ratio

0.56

EPS Next Q Diff

1.73

EPS Last/This Y

-0.77

EPS This/Next Y

0.39

Price

28.43

Target Price

Analyst Recom

Performance Q

-23.62

Upside

N/A

Beta

Ticker: PBLS

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	PBLS	25.9	0.52	0.67	574
2026-10-15	PBLS	25.16	0.52	999.99	582
2026-10-16	PBLS	22.69	0.52	999.99	582
2026-10-19	PBLS	25.34	0.29	0.35	409
2026-10-20	PBLS	27.12	0.27	0.00	433
2026-10-21	PBLS	27.86	0.25	0.00	468
2026-10-22	PBLS	26.93	0.25	0.00	479
2026-10-23	PBLS	24.43	0.24	0.30	484
2026-10-26	PBLS	25.01	0.24	999.99	495
2026-10-27	PBLS	26.6	0.24	999.99	495
2026-10-28	PBLS	28.28	0.24	999.99	495
2026-10-29	PBLS	28.74	0.21	1.00	481
2026-10-30	PBLS	28.37	0.21	53.33	481
2026-11-02	PBLS	27.27	0.21	14.55	481
2026-11-03	PBLS	29.31	0.54	0.00	621
2026-11-04	PBLS	30.38	0.54	0.67	622
2026-11-05	PBLS	27.89	0.54	5.00	613
2026-11-06	PBLS	28.56	0.52	999.99	605
2026-11-09	PBLS	30.34	0.56	0.00	620
2026-11-10	PBLS	30.06	0.56	0.00	620
2026-11-11	PBLS	29.64	0.56	0.00	621
2026-11-12	PBLS	27.69	0.56	0.00	621
2026-11-13	PBLS	28.47	0.56	999.99	624
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	PBLS	25.90	-	-	-2.58
2026-10-15	PBLS	25.19	-	-	-2.58
2026-10-16	PBLS	22.74	-	-	-2.58
2026-10-19	PBLS	25.34	-	-	-2.58
2026-10-20	PBLS	25.34	-	-	-2.58
2026-10-21	PBLS	27.06	-	-	-2.58
2026-10-22	PBLS	26.90	-	-	-2.58
2026-10-23	PBLS	24.47	-	-	-2.58
2026-10-26	PBLS	25.00	-	-	-2.58
2026-10-27	PBLS	26.55	-	-	-2.58
2026-10-28	PBLS	28.22	-	-	-2.58
2026-10-29	PBLS	28.70	-	-	-2.58
2026-10-30	PBLS	28.33	-	-	-2.58
2026-11-02	PBLS	27.31	-	-	-2.58
2026-11-03	PBLS	29.28	-	-	-2.58
2026-11-04	PBLS	30.39	-	-	-2.58
2026-11-05	PBLS	27.89	-	-	-2.58
2026-11-06	PBLS	28.52	-	-	-2.58
2026-11-09	PBLS	30.38	-	-	-2.58
2026-11-10	PBLS	30.03	-	-	-2.58
2026-11-11	PBLS	29.64	-	-	-2.58
2026-11-12	PBLS	27.72	-	-	-2.58
2026-11-13	PBLS	28.43	-	-	-2.58
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	PBLS	91.17	120.57	10.66
2026-10-15	PBLS	91.17	120.57	10.66
2026-10-16	PBLS	91.17	120.57	10.66
2026-10-19	PBLS	91.18	120.65	10.66
2026-10-20	PBLS	91.18	120.65	10.66
2026-10-21	PBLS	91.17	120.65	10.66
2026-10-22	PBLS	91.17	120.65	10.66
2026-10-23	PBLS	91.17	120.65	10.66
2026-10-26	PBLS	91.18	117.31	10.66
2026-10-27	PBLS	91.17	117.31	11.94
2026-10-28	PBLS	91.17	117.31	11.94
2026-10-29	PBLS	91.17	117.31	11.94
2026-10-30	PBLS	91.17	117.31	11.94
2026-11-02	PBLS	91.17	120.69	11.94
2026-11-03	PBLS	91.17	120.69	11.94
2026-11-05	PBLS	91.17	120.69	11.94
2026-11-06	PBLS	91.17	120.69	11.94
2026-11-09	PBLS	91.17	113.62	11.94
2026-11-10	PBLS	91.17	113.62	11.94
2026-11-11	PBLS	91.17	113.62	14.26
2026-11-12	PBLS	91.17	113.62	14.26
2026-11-13	PBLS	91.17	113.62	14.26
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=PBLS 589 360 ]

Last Quarter Act. EPS

-2.13

Avg. EPS Est. Current Quarter

-0.38

Avg. EPS Est. Next Quarter

-0.4

Insider Transactions

91.17

Institutional Transactions

113.62

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

33.1

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

3.5

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y

-2.58

EPS Next Y. (Est.)

-2.19

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.59

Return on Equity vs Sector %

-48.5

Return on Equity vs Industry %

-29.4

EPS 1 7Days Diff

-0.9

EPS 1 30Days Diff

-0.92

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=PBLS 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=PBLS 589 450 ]

◆ PBLS Healthcare

$28.43

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

11/25

Volume

11/15

Valuation

8/20

TP/AR

6/10

Options

3/10

RSI

48.6

Range 1M

59.7%

Sup Dist

5.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

6/30

Estimates

4/20

Inst/Vol

5/15

Options

3/10

EPS Yr

EPS NY

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +44.2% upside

Quality

3/30

Valuation

11/30

Growth

4/25

Stability

7/10

LT Trend

1/5

Upside

+44.2%

Quality

PBLS — P/E HistoricalBiotechnology

Parabilis Medicines, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 145

Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment. The company develops stabilized helical peptide therapeutics through its Helicon discovery platform, targeting proteins that are traditionally considered undruggable. Its pipeline includes functional inhibitors of intracellular protein-protein interactions, targeted protein degraders, and targeted radiopharmaceuticals, with a lead clinical program, FOG-001, that acts as a TCF-blocking beta-catenin inhibitor for cancer treatment. The company integrates artificial intelligence and data science into drug discovery, trial design, and clinical strategy optimization. Parabilis Medicines serves clients in the healthcare and life sciences industries, including clinical research organizations and medical professionals involved in oncology and cancer treatment. The company was founded in 2015 and is based in Cambridge, Massachusetts.

PBLS

Latest News

—

Caricamento notizie per PBLS…

stock quote shares PBLS – Parabilis Medicines Inc Stock Price stock today

news today PBLS – Parabilis Medicines Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch PBLS – Parabilis Medicines Inc yahoo finance google finance

stock history PBLS – Parabilis Medicines Inc invest stock market

stock prices PBLS premarket after hours

ticker PBLS fair value insiders trading

ROIV – Roivant Sciences Ltd

ROIV — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

8.65

Margin Of Safety %

Put/Call OI Ratio

0.42

EPS Next Q Diff

-0.1

EPS Last/This Y

-1.04

EPS This/Next Y

0.12

Price

39.53

Target Price

50.82

Analyst Recom

1.4

Performance Q

9.08

Upside

-118.4%

Beta

1.2

Ticker: ROIV

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	ROIV	33.62	0.46	0.07	80723
2026-10-15	ROIV	34.04	0.46	0.80	80709
2026-10-16	ROIV	33.52	0.46	0.10	80719
2026-10-19	ROIV	34.68	0.46	0.22	79712
2026-10-20	ROIV	34.92	0.46	0.13	79719
2026-10-21	ROIV	36.81	0.46	0.85	79757
2026-10-22	ROIV	37.44	0.48	0.00	81934
2026-10-23	ROIV	36.53	0.48	0.04	81831
2026-10-26	ROIV	36.06	0.48	0.33	81839
2026-10-27	ROIV	36.57	0.48	0.33	81820
2026-10-28	ROIV	37.1	0.48	0.92	81834
2026-10-29	ROIV	37.51	0.48	0.00	81941
2026-10-30	ROIV	36.86	0.48	1.34	81881
2026-11-02	ROIV	35.9	0.48	0.00	82010
2026-11-03	ROIV	36.06	0.48	0.70	82014
2026-11-04	ROIV	38.22	0.48	0.00	82030
2026-11-05	ROIV	36.61	0.48	0.47	82418
2026-11-06	ROIV	38.89	0.48	0.06	82447
2026-11-09	ROIV	40.67	0.48	0.02	82885
2026-11-10	ROIV	41.17	0.47	0.01	83131
2026-11-11	ROIV	41.85	0.47	0.00	83000
2026-11-12	ROIV	39.97	0.41	0.51	91446
2026-11-13	ROIV	39.54	0.42	0.02	91867
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	ROIV	33.62	-63.3	-	-1.58
2026-10-15	ROIV	34.05	-63.3	-	-1.58
2026-10-16	ROIV	33.52	-63.3	-	-1.58
2026-10-19	ROIV	34.71	-63.3	-	-1.58
2026-10-20	ROIV	34.71	-63.3	-	-1.58
2026-10-21	ROIV	34.93	-63.3	-	-1.58
2026-10-22	ROIV	37.44	-63.3	-	-1.58
2026-10-23	ROIV	36.49	-63.3	-	-1.58
2026-10-26	ROIV	36.06	-63.3	-	-1.58
2026-10-27	ROIV	36.57	-63.3	-	-1.58
2026-10-28	ROIV	37.10	-63.3	-	-1.58
2026-10-29	ROIV	37.50	-63.3	-	-1.58
2026-10-30	ROIV	36.91	-63.3	-	-1.58
2026-11-02	ROIV	35.89	-63.3	-	-1.58
2026-11-03	ROIV	36.06	-62.7	-	-1.56
2026-11-04	ROIV	38.22	-62.7	-	-1.56
2026-11-05	ROIV	36.63	-62.7	-	-1.56
2026-11-06	ROIV	38.92	-62.7	-	-1.56
2026-11-09	ROIV	40.67	-62.7	-	-1.56
2026-11-10	ROIV	41.17	-62.7	-	-1.56
2026-11-11	ROIV	41.85	-68.3	-	-1.56
2026-11-12	ROIV	39.98	-68.3	-	-1.56
2026-11-13	ROIV	39.53	-62.7	-	-1.47
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	ROIV	-3.92	3.89	7.50
2026-10-15	ROIV	-3.92	3.89	7.50
2026-10-16	ROIV	-3.92	3.89	7.50
2026-10-19	ROIV	-3.92	3.89	7.50
2026-10-20	ROIV	-3.92	3.89	7.50
2026-10-21	ROIV	-3.78	3.89	7.50
2026-10-22	ROIV	-3.78	3.89	7.50
2026-10-23	ROIV	-3.78	3.89	7.50
2026-10-26	ROIV	-3.78	3.25	7.50
2026-10-27	ROIV	-3.78	3.25	7.69
2026-10-28	ROIV	-3.78	3.25	7.69
2026-10-29	ROIV	-3.78	3.25	7.69
2026-10-30	ROIV	-3.78	3.25	7.69
2026-11-02	ROIV	-3.88	4.47	7.69
2026-11-03	ROIV	-3.88	4.47	7.69
2026-11-05	ROIV	-3.88	4.47	7.69
2026-11-06	ROIV	-3.97	4.47	7.69
2026-11-09	ROIV	-3.97	2.79	7.69
2026-11-10	ROIV	-3.97	2.79	7.69
2026-11-11	ROIV	-3.97	2.79	8.68
2026-11-12	ROIV	-3.96	2.79	8.65
2026-11-13	ROIV	-4.19	2.79	8.65
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.3

Avg. EPS Est. Current Quarter

-0.4

Avg. EPS Est. Next Quarter

-0.4

Insider Transactions

-4.19

Institutional Transactions

2.79

Beta

1.2

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-79.2

Target Price

50.82

P/E

Forward P/E

PEG

P/S

697.22

P/B

7.12

P/Free Cash Flow

EPS

-0.56

Average EPS Est. Cur. Y

-1.47

EPS Next Y. (Est.)

-1.36

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-876.58

Relative Volume

0.88

Return on Equity vs Sector %

-35

Return on Equity vs Industry %

-15.8

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.11

EBIT Estimation

◆ ROIV Healthcare

$39.53

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

10/25

Volume

4/15

Valuation

6/20

TP/AR

5/10

Options

7/10

RSI

57.1

Range 1M

68.3%

Sup Dist

0.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

12/30

Estimates

6/20

Inst/Vol

6/15

Options

9/10

EPS Yr

-112.8%

EPS NY

0.9%

52W%

85.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +28.6% upside

Quality

7/30

Valuation

6/30

Growth

9/25

Stability

7/10

LT Trend

1/5

Upside

+28.6%

Quality

ROIV — P/E HistoricalBiotechnology

Roivant Sciences Ltd.

Sector: Healthcare

Industry: Biotechnology

Employees: 721

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

ROIV

Latest News

—

Caricamento notizie per ROIV…

stock quote shares ROIV – Roivant Sciences Ltd Stock Price stock today

news today ROIV – Roivant Sciences Ltd stock forecast ,stock prediction 2023 2024 2025

marketwatch ROIV – Roivant Sciences Ltd yahoo finance google finance

stock history ROIV – Roivant Sciences Ltd invest stock market

stock prices ROIV premarket after hours

ticker ROIV fair value insiders trading

RNAM – Avidity Biosciences Inc

RGC – Regencell Bioscience Holdings Ltd

RGC — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.62

Margin Of Safety %

Put/Call OI Ratio

1.06

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

4.91

Target Price

Analyst Recom

Performance Q

-7.66

Upside

-105.3%

Beta

1.75

Ticker: RGC

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	RGC	8.07	1.36	0.05	6521
2026-10-15	RGC	9.4	1.31	0.37	6634
2026-10-16	RGC	9.63	1.03	0.91	8856
2026-10-19	RGC	10.09	2.14	1.40	4758
2026-10-20	RGC	10.36	1.46	2.25	4309
2026-10-21	RGC	10.87	1.67	0.12	4441
2026-10-22	RGC	9.85	1.63	0.05	4503
2026-10-23	RGC	7.61	1.73	0.01	4406
2026-10-26	RGC	6.75	1.64	0.06	4499
2026-10-27	RGC	7.45	1.52	0.02	4637
2026-10-28	RGC	7.33	1.56	0.00	4590
2026-10-29	RGC	6.83	1.42	0.00	4761
2026-10-30	RGC	6.61	1.40	0.00	4794
2026-11-02	RGC	6.25	1.41	0.00	4786
2026-11-03	RGC	6.1938	1.41	0.00	4787
2026-11-04	RGC	5.39	1.40	0.25	4788
2026-11-05	RGC	5.27	1.37	1.67	4801
2026-11-06	RGC	5.32	1.38	29.00	4818
2026-11-09	RGC	5.595	1.01	2.37	4111
2026-11-10	RGC	5.24	1.03	95.00	4160
2026-11-11	RGC	5.42	1.08	0.95	4254
2026-11-12	RGC	5.14	1.07	0.05	4312
2026-11-13	RGC	5.02	1.06	0.06	4318
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	RGC	8.05	-	-	-
2026-10-15	RGC	9.36	-	-	-
2026-10-16	RGC	9.61	-	-	-
2026-10-19	RGC	10.10	-	-	-
2026-10-20	RGC	10.10	-	-	-
2026-10-21	RGC	10.41	-	-	-
2026-10-22	RGC	9.85	-	-	-
2026-10-23	RGC	7.61	-	-	-
2026-10-26	RGC	6.78	-	-	-
2026-10-27	RGC	7.41	-	-	-
2026-10-28	RGC	7.20	-	-	-
2026-10-29	RGC	6.85	-	-	-
2026-10-30	RGC	6.66	-	-	-
2026-11-02	RGC	6.27	-	-	-
2026-11-03	RGC	6.11	-	-	-
2026-11-04	RGC	5.41	-	-	-
2026-11-05	RGC	5.26	-	-	-
2026-11-06	RGC	5.32	-	-	-
2026-11-09	RGC	5.62	-	-	-
2026-11-10	RGC	5.24	-	-	-
2026-11-11	RGC	5.45	-	-	-
2026-11-12	RGC	5.16	-	-	-
2026-11-13	RGC	4.91	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	RGC	0.00	63.32	1.17
2026-10-15	RGC	0.00	63.32	1.17
2026-10-16	RGC	0.00	63.32	1.17
2026-10-19	RGC	0.00	63.32	1.17
2026-10-20	RGC	0.00	63.32	1.17
2026-10-21	RGC	0.00	63.32	1.17
2026-10-22	RGC	0.00	63.32	1.17
2026-10-23	RGC	0.00	63.32	1.17
2026-10-26	RGC	0.00	63.29	1.17
2026-10-27	RGC	0.00	63.29	0.78
2026-10-28	RGC	0.00	63.29	0.78
2026-10-29	RGC	0.00	63.29	0.78
2026-10-30	RGC	0.00	63.29	0.78
2026-11-02	RGC	0.00	64.45	0.78
2026-11-03	RGC	0.00	64.45	0.78
2026-11-05	RGC	0.00	64.45	0.78
2026-11-06	RGC	0.00	64.45	0.78
2026-11-09	RGC	0.00	63.18	0.78
2026-11-10	RGC	0.00	63.18	0.78
2026-11-11	RGC	0.00	63.18	0.62
2026-11-12	RGC	0.00	63.18	0.62
2026-11-13	RGC	0.00	63.18	0.62
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

63.18

Beta

1.75

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

94.1

Max Drawdown 5-Year %

-93.9

Target Price

P/E

Forward P/E

PEG

P/S

P/B

183.51

P/Free Cash Flow

EPS

-0.02

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.49

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-94.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ RGC Healthcare

$4.94

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

18/20

Pullback

15/25

Volume

11/15

Valuation

6/20

TP/AR

2/10

Options

1/10

RSI

34.5

Range 1M

2.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

4/30

Estimates

0/20

Inst/Vol

5/15

Options

5/10

EPS Yr

EPS NY

52W%

0.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

Quality

2/30

Valuation

2/30

Growth

0/25

Stability

7/10

LT Trend

4/5

Quality

RGC — P/E HistoricalDrug Manufacturers - Specialty & Generic

Regencell Bioscience Holdings L

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 10

Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

RGC

Latest News

—

Caricamento notizie per RGC…

stock quote shares RGC – Regencell Bioscience Holdings Ltd Stock Price stock today

news today RGC – Regencell Bioscience Holdings Ltd stock forecast ,stock prediction 2023 2024 2025

marketwatch RGC – Regencell Bioscience Holdings Ltd yahoo finance google finance

stock history RGC – Regencell Bioscience Holdings Ltd invest stock market

stock prices RGC premarket after hours

ticker RGC fair value insiders trading

ONC – BeOne Medicines Ltd ADR

ONC — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.53

Margin Of Safety %

-16

Put/Call OI Ratio

0.76

EPS Next Q Diff

-1.63

EPS Last/This Y

1.81

EPS This/Next Y

0.85

Price

416.57

Target Price

469.12

Analyst Recom

1.28

Performance Q

14.9

Upside

-33.7%

Beta

0.62

Ticker: ONC

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	ONC	351.57	0.62	0.25	1560
2026-10-15	ONC	374.3	0.62	0.03	1543
2026-10-16	ONC	369.31	0.67	0.69	1476
2026-10-19	ONC	370.36	0.74	0.36	1333
2026-10-20	ONC	384.79	0.74	0.95	1354
2026-10-21	ONC	386.37	0.75	0.62	1410
2026-10-22	ONC	382.59	0.75	0.06	1448
2026-10-23	ONC	377.95	0.58	0.63	1725
2026-10-26	ONC	371.05	0.58	0.50	1746
2026-10-27	ONC	367.05	0.59	2.73	1747
2026-10-28	ONC	373.5	0.60	0.88	1764
2026-10-29	ONC	371.57	0.63	0.00	2059
2026-10-30	ONC	370.29	0.63	0.00	2061
2026-11-02	ONC	361.04	0.63	8.00	2064
2026-11-03	ONC	354.89	0.63	0.08	2066
2026-11-04	ONC	378.19	0.63	1.98	2079
2026-11-05	ONC	387.53	0.97	0.07	3245
2026-11-06	ONC	407.17	0.79	0.80	3633
2026-11-09	ONC	417.6	0.80	1.02	3695
2026-11-10	ONC	424.19	0.80	0.52	3759
2026-11-11	ONC	420.05	0.79	0.14	3848
2026-11-12	ONC	416.07	0.78	0.23	3910
2026-11-13	ONC	416.67	0.76	5.19	4033
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	ONC	351.45	72.3	497.7	7.64
2026-10-15	ONC	375.01	72.3	603.4	7.64
2026-10-16	ONC	368.56	72.3	565.0	7.64
2026-10-19	ONC	370.04	72.3	503.2	7.64
2026-10-20	ONC	370.04	72.3	503.2	7.64
2026-10-21	ONC	384.79	72.3	565.9	7.64
2026-10-22	ONC	382.27	72.3	503.4	7.64
2026-10-23	ONC	377.94	72.3	502.6	7.64
2026-10-26	ONC	369.77	72.7	465.9	7.64
2026-10-27	ONC	366.47	72.7	482.2	7.64
2026-10-28	ONC	373.91	72.7	513.7	7.64
2026-10-29	ONC	370.54	72.7	537.4	7.64
2026-10-30	ONC	369.53	72.7	519.2	7.64
2026-11-02	ONC	362.39	72.7	496.3	7.64
2026-11-03	ONC	355.00	72.7	464.3	7.64
2026-11-04	ONC	377.88	72.7	647.6	7.64
2026-11-05	ONC	388.51	72.7	533.8	7.64
2026-11-06	ONC	407.61	72.7	401.9	7.64
2026-11-09	ONC	418.03	164.0	215.7	7.64
2026-11-10	ONC	424.39	311.1	212.4	7.64
2026-11-11	ONC	420.99	338.7	176.3	7.64
2026-11-12	ONC	416.49	338.7	160.9	7.64
2026-11-13	ONC	416.57	354.2	121.4	9.87
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	ONC	-64.87	1.94	1.86
2026-10-15	ONC	-64.87	1.94	1.86
2026-10-16	ONC	-65.55	1.94	1.86
2026-10-19	ONC	-65.55	1.94	1.86
2026-10-20	ONC	-65.55	1.94	1.86
2026-10-21	ONC	-65.55	1.94	1.86
2026-10-22	ONC	-65.55	1.94	1.86
2026-10-23	ONC	-65.55	1.94	1.86
2026-10-26	ONC	-65.55	1.86	1.86
2026-10-27	ONC	-65.55	1.86	1.73
2026-10-28	ONC	-65.55	1.86	1.73
2026-10-29	ONC	-65.55	1.86	1.73
2026-10-30	ONC	-66.21	1.86	1.73
2026-11-02	ONC	-66.21	2.00	1.73
2026-11-03	ONC	-66.21	2.00	1.73
2026-11-05	ONC	-66.21	2.00	1.73
2026-11-06	ONC	-66.21	2.00	1.73
2026-11-09	ONC	-66.21	1.37	0
2026-11-10	ONC	-66.01	1.37	1.71
2026-11-11	ONC	-66.04	1.37	1.53
2026-11-12	ONC	-66.04	1.37	1.53
2026-11-13	ONC	-66.04	1.37	1.53
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

3.64

Avg. EPS Est. Current Quarter

2.63

Avg. EPS Est. Next Quarter

2.01

Insider Transactions

-66.04

Institutional Transactions

1.37

Beta

0.62

Average Sales Estimate Current Quarter

1878

Average Sales Estimate Next Quarter

1763

Fair Value

350.39

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

1.9

Max Drawdown 5-Year %

-68.9

Target Price

469.12

P/E

52.81

Forward P/E

38.76

PEG

0.52

P/S

6.62

P/B

8.17

P/Free Cash Flow

30.18

EPS

7.89

Average EPS Est. Cur. Y

9.87

EPS Next Y. (Est.)

10.72

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.86

Relative Volume

0.46

Return on Equity vs Sector %

-10.7

Return on Equity vs Industry %

8.5

EPS 1 7Days Diff

2.2

EPS 1 30Days Diff

2.23

EBIT Estimation

121.4

◆ ONC Healthcare

$416.54

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

2/20

Pullback

8/25

Volume

8/15

Valuation

9/20

TP/AR

2/10

Options

2/10

RSI

67.5

Range 1M

89.2%

Sup Dist

0.8%

🚀

Momentum Growth

Ride accelerating trends

WATCH

Momentum

13/25

Growth

27/30

Estimates

6/20

Inst/Vol

6/15

Options

5/10

EPS Yr

235.1%

EPS NY

21.9%

52W%

95%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -7.2% upside

Quality

21/30

Valuation

4/30

Growth

22/25

Stability

5/10

LT Trend

1/5

Upside

-7.2%

Quality

MoS

-16%

ONC — P/E HistoricalBiotechnology

BeOne Medicines Ltd.

Sector: Healthcare

Industry: Biotechnology

Employees: 12000

BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; SYLVANT for the treatment of adult patients with multicentric castleman disease; BAITUOWEI for patients with BC in premenopausal and perimenopausal women, and cancer; and PARTRUVIX for the treatment of various solid tumors. Its clinical stage products comprise Sonrotoclax BGB-11417, a small molecule Bcl-2 inhibitor; BGB-16673, a BTK targeting chimeric degradation activation compound active against wild type and mutant BTK; BG-60366, an EGFR-targeted CDAC; BG-89894 (SYH2039), a MAT2A Inhibitor; BGB-58067, an MTA-Cooperative PRMT5 Inhibitor; BG-T187 and BG-C0902, an anti-EGFRxMET trispecific antibody; BGB-26808, a HPK-1 Inhibitor; BGB-C354, an anti-B7H3 ADC; Zanidatamab, a bispecific HER2-targeted antibody; BG-C137, an anti-FGFR2b ADC; BGB-53038, a Pan-KRAS Inhibitor; BGB-B2033, an anti-GPC3x4-1BB bispecific antibody; BGB-B3227, an anti-MUC1xCD16A bispecific antibody; BG-C477, an anti-CEAADC; BGB-43395, a CDK4 Inhibitor; BG-68501, a CDK2 Inhibitor; BG-C9074, an anti-B7H4 ADC; BGB-21447, a Bcl-2 Inhibitor; and BGB-45035, an IRAK4-targeted CDAC. It also has various preclinical programs. The company has agreements Amgen, BMS, Bio-Thera, EUSA Pharma, Luye Pharmaceutical, and Novartis. The company was formerly known as BeiGene, Ltd. and changed its name to BeOne Medicines AG in May 2025. The company has a agreement with U.S. government to expand access to innovative cancer medicines. BeOne Medicines AG was founded in 2010 and is based in Basel, Switzerland.

ONC

Latest News

—

Caricamento notizie per ONC…

stock quote shares ONC – BeOne Medicines Ltd ADR Stock Price stock today

news today ONC – BeOne Medicines Ltd ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch ONC – BeOne Medicines Ltd ADR yahoo finance google finance

stock history ONC – BeOne Medicines Ltd ADR invest stock market

stock prices ONC premarket after hours

ticker ONC fair value insiders trading

No more stocks to show

HIMS – Hims & Hers Health, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: HIMS

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

PBLS – Parabilis Medicines Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: PBLS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y